RARE

Ultragenyx Pharmaceutical Inc.

Healthcare›Biotechnology|NASDAQ Global Select|US

Price

$22.45

Market Cap

$2.17B

Beta

0.25

P/E

0.0

Div Yield

—

Sector Median P/E

22.6

Key Metrics

Revenue Growth (YoY)+20.08%

EPS Growth (YoY)+7.89%

Revenue CAGR 3Y+22.79%

P/E Ratio0.0

PEG Ratio—

FCF Yield-21.76%

Debt / Equity0.00

Interest Coverage-8.7x

No credit card required

Already have an account? Sign in to view the full analysis for RARE.